nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP3A4—prostate cancer	0.225	1	CbGaD
Levobupivacaine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.064	0.138	CbGbCtD
Levobupivacaine—CYP1A2—Flutamide—prostate cancer	0.0532	0.115	CbGbCtD
Levobupivacaine—CYP1A2—Estrone—prostate cancer	0.0385	0.0831	CbGbCtD
Levobupivacaine—CYP3A4—Bicalutamide—prostate cancer	0.0336	0.0726	CbGbCtD
Levobupivacaine—CYP3A4—Estramustine—prostate cancer	0.0313	0.0675	CbGbCtD
Levobupivacaine—CYP3A4—Abiraterone—prostate cancer	0.0279	0.0602	CbGbCtD
Levobupivacaine—CYP3A4—Flutamide—prostate cancer	0.0279	0.0602	CbGbCtD
Levobupivacaine—CYP1A2—Conjugated Estrogens—prostate cancer	0.0252	0.0543	CbGbCtD
Levobupivacaine—CYP1A2—Estradiol—prostate cancer	0.0221	0.0477	CbGbCtD
Levobupivacaine—CYP3A4—Cabazitaxel—prostate cancer	0.0206	0.0445	CbGbCtD
Levobupivacaine—CYP3A4—Estrone—prostate cancer	0.0201	0.0435	CbGbCtD
Levobupivacaine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.018	0.0388	CbGbCtD
Levobupivacaine—CYP1A2—Etoposide—prostate cancer	0.0144	0.0311	CbGbCtD
Levobupivacaine—CYP3A4—Conjugated Estrogens—prostate cancer	0.0132	0.0285	CbGbCtD
Levobupivacaine—CYP3A4—Mitoxantrone—prostate cancer	0.012	0.0259	CbGbCtD
Levobupivacaine—CYP3A4—Estradiol—prostate cancer	0.0116	0.025	CbGbCtD
Levobupivacaine—CYP3A4—Prednisone—prostate cancer	0.00995	0.0215	CbGbCtD
Levobupivacaine—CYP3A4—Etoposide—prostate cancer	0.00756	0.0163	CbGbCtD
Levobupivacaine—CYP3A4—Docetaxel—prostate cancer	0.00691	0.0149	CbGbCtD
Levobupivacaine—CYP3A4—Doxorubicin—prostate cancer	0.00515	0.0111	CbGbCtD
Levobupivacaine—Lidocaine—CYP2C18—prostate cancer	0.000626	0.182	CrCbGaD
Levobupivacaine—Lidocaine—EGFR—prostate cancer	0.000489	0.142	CrCbGaD
Levobupivacaine—Bupivacaine—CYP2C19—prostate cancer	0.000479	0.139	CrCbGaD
Levobupivacaine—CYP1A2—urine—prostate cancer	0.000448	0.235	CbGeAlD
Levobupivacaine—Lidocaine—CYP3A5—prostate cancer	0.000412	0.12	CrCbGaD
Levobupivacaine—Lidocaine—CYP2A6—prostate cancer	0.000399	0.116	CrCbGaD
Levobupivacaine—SCN4A—prostate gland—prostate cancer	0.000394	0.207	CbGeAlD
Levobupivacaine—CYP3A4—urine—prostate cancer	0.000324	0.17	CbGeAlD
Levobupivacaine—Ranolazine—CYP3A4—prostate cancer	0.000311	0.0902	CrCbGaD
Levobupivacaine—Bupivacaine—CYP3A4—prostate cancer	0.000305	0.0885	CrCbGaD
Levobupivacaine—SCN4A—renal system—prostate cancer	0.000269	0.141	CbGeAlD
Levobupivacaine—Ropivacaine—CYP3A4—prostate cancer	0.000246	0.0713	CrCbGaD
Levobupivacaine—Lidocaine—CYP3A4—prostate cancer	0.000178	0.0518	CrCbGaD
Levobupivacaine—SCN4A—testis—prostate cancer	0.000174	0.0911	CbGeAlD
Levobupivacaine—CYP1A2—renal system—prostate cancer	0.00011	0.0576	CbGeAlD
Levobupivacaine—SCN10A—lymph node—prostate cancer	0.000107	0.0564	CbGeAlD
Levobupivacaine—CYP3A4—renal system—prostate cancer	7.94e-05	0.0417	CbGeAlD
Levobupivacaine—Anxiety—Capecitabine—prostate cancer	6.65e-05	0.000301	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	6.63e-05	0.0003	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Docetaxel—prostate cancer	6.61e-05	0.000299	CcSEcCtD
Levobupivacaine—Oedema—Docetaxel—prostate cancer	6.61e-05	0.000299	CcSEcCtD
Levobupivacaine—Vision blurred—Prednisone—prostate cancer	6.58e-05	0.000298	CcSEcCtD
Levobupivacaine—Infection—Docetaxel—prostate cancer	6.57e-05	0.000297	CcSEcCtD
Levobupivacaine—Feeling abnormal—Etoposide—prostate cancer	6.55e-05	0.000297	CcSEcCtD
Levobupivacaine—Diarrhoea—Mitoxantrone—prostate cancer	6.54e-05	0.000296	CcSEcCtD
Levobupivacaine—Vomiting—Estradiol—prostate cancer	6.52e-05	0.000296	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Etoposide—prostate cancer	6.5e-05	0.000295	CcSEcCtD
Levobupivacaine—Shock—Docetaxel—prostate cancer	6.5e-05	0.000295	CcSEcCtD
Levobupivacaine—Nervous system disorder—Docetaxel—prostate cancer	6.48e-05	0.000294	CcSEcCtD
Levobupivacaine—Infestation—Doxorubicin—prostate cancer	6.47e-05	0.000293	CcSEcCtD
Levobupivacaine—Infestation NOS—Doxorubicin—prostate cancer	6.47e-05	0.000293	CcSEcCtD
Levobupivacaine—Drowsiness—Doxorubicin—prostate cancer	6.47e-05	0.000293	CcSEcCtD
Levobupivacaine—Anaemia—Prednisone—prostate cancer	6.46e-05	0.000292	CcSEcCtD
Levobupivacaine—Confusional state—Capecitabine—prostate cancer	6.45e-05	0.000292	CcSEcCtD
Levobupivacaine—Tachycardia—Docetaxel—prostate cancer	6.45e-05	0.000292	CcSEcCtD
Levobupivacaine—Headache—Estradiol—prostate cancer	6.43e-05	0.000291	CcSEcCtD
Levobupivacaine—Skin disorder—Docetaxel—prostate cancer	6.42e-05	0.000291	CcSEcCtD
Levobupivacaine—Agitation—Prednisone—prostate cancer	6.42e-05	0.000291	CcSEcCtD
Levobupivacaine—Oedema—Capecitabine—prostate cancer	6.4e-05	0.00029	CcSEcCtD
Levobupivacaine—Bradycardia—Epirubicin—prostate cancer	6.39e-05	0.000289	CcSEcCtD
Levobupivacaine—Angioedema—Prednisone—prostate cancer	6.38e-05	0.000289	CcSEcCtD
Levobupivacaine—Infection—Capecitabine—prostate cancer	6.36e-05	0.000288	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Doxorubicin—prostate cancer	6.34e-05	0.000287	CcSEcCtD
Levobupivacaine—Urticaria—Etoposide—prostate cancer	6.32e-05	0.000286	CcSEcCtD
Levobupivacaine—Shock—Capecitabine—prostate cancer	6.3e-05	0.000285	CcSEcCtD
Levobupivacaine—Body temperature increased—Etoposide—prostate cancer	6.29e-05	0.000285	CcSEcCtD
Levobupivacaine—Abdominal pain—Etoposide—prostate cancer	6.29e-05	0.000285	CcSEcCtD
Levobupivacaine—Urinary tract infection—Doxorubicin—prostate cancer	6.29e-05	0.000285	CcSEcCtD
Levobupivacaine—Nervous system disorder—Capecitabine—prostate cancer	6.28e-05	0.000284	CcSEcCtD
Levobupivacaine—Syncope—Prednisone—prostate cancer	6.26e-05	0.000284	CcSEcCtD
Levobupivacaine—Tachycardia—Capecitabine—prostate cancer	6.25e-05	0.000283	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Epirubicin—prostate cancer	6.24e-05	0.000283	CcSEcCtD
Levobupivacaine—Skin disorder—Capecitabine—prostate cancer	6.22e-05	0.000282	CcSEcCtD
Levobupivacaine—Sweating—Doxorubicin—prostate cancer	6.2e-05	0.000281	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Capecitabine—prostate cancer	6.19e-05	0.00028	CcSEcCtD
Levobupivacaine—Oedema peripheral—Epirubicin—prostate cancer	6.18e-05	0.00028	CcSEcCtD
Levobupivacaine—Hypotension—Docetaxel—prostate cancer	6.18e-05	0.00028	CcSEcCtD
Levobupivacaine—Haematuria—Doxorubicin—prostate cancer	6.17e-05	0.000279	CcSEcCtD
Levobupivacaine—Loss of consciousness—Prednisone—prostate cancer	6.14e-05	0.000278	CcSEcCtD
Levobupivacaine—Nausea—Estradiol—prostate cancer	6.09e-05	0.000276	CcSEcCtD
Levobupivacaine—Vomiting—Mitoxantrone—prostate cancer	6.08e-05	0.000275	CcSEcCtD
Levobupivacaine—Convulsion—Prednisone—prostate cancer	6.05e-05	0.000274	CcSEcCtD
Levobupivacaine—Hypertension—Prednisone—prostate cancer	6.03e-05	0.000273	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Docetaxel—prostate cancer	6.02e-05	0.000273	CcSEcCtD
Levobupivacaine—Headache—Mitoxantrone—prostate cancer	5.99e-05	0.000271	CcSEcCtD
Levobupivacaine—Hypotension—Capecitabine—prostate cancer	5.98e-05	0.000271	CcSEcCtD
Levobupivacaine—Insomnia—Docetaxel—prostate cancer	5.98e-05	0.000271	CcSEcCtD
Levobupivacaine—Arthralgia—Prednisone—prostate cancer	5.95e-05	0.000269	CcSEcCtD
Levobupivacaine—Paraesthesia—Docetaxel—prostate cancer	5.93e-05	0.000269	CcSEcCtD
Levobupivacaine—Anxiety—Prednisone—prostate cancer	5.93e-05	0.000268	CcSEcCtD
Levobupivacaine—Bradycardia—Doxorubicin—prostate cancer	5.91e-05	0.000268	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.9e-05	0.000268	CcSEcCtD
Levobupivacaine—Dyspnoea—Docetaxel—prostate cancer	5.89e-05	0.000267	CcSEcCtD
Levobupivacaine—Somnolence—Docetaxel—prostate cancer	5.88e-05	0.000266	CcSEcCtD
Levobupivacaine—Hypersensitivity—Etoposide—prostate cancer	5.86e-05	0.000265	CcSEcCtD
Levobupivacaine—Tinnitus—Epirubicin—prostate cancer	5.85e-05	0.000265	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.83e-05	0.000264	CcSEcCtD
Levobupivacaine—Cardiac disorder—Epirubicin—prostate cancer	5.82e-05	0.000264	CcSEcCtD
Levobupivacaine—Flushing—Epirubicin—prostate cancer	5.82e-05	0.000264	CcSEcCtD
Levobupivacaine—Dyspepsia—Docetaxel—prostate cancer	5.82e-05	0.000264	CcSEcCtD
Levobupivacaine—Insomnia—Capecitabine—prostate cancer	5.79e-05	0.000262	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Doxorubicin—prostate cancer	5.78e-05	0.000262	CcSEcCtD
Levobupivacaine—Paraesthesia—Capecitabine—prostate cancer	5.75e-05	0.00026	CcSEcCtD
Levobupivacaine—Decreased appetite—Docetaxel—prostate cancer	5.75e-05	0.00026	CcSEcCtD
Levobupivacaine—Oedema peripheral—Doxorubicin—prostate cancer	5.72e-05	0.000259	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Docetaxel—prostate cancer	5.71e-05	0.000259	CcSEcCtD
Levobupivacaine—Asthenia—Etoposide—prostate cancer	5.71e-05	0.000258	CcSEcCtD
Levobupivacaine—Dyspnoea—Capecitabine—prostate cancer	5.7e-05	0.000258	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Prednisone—prostate cancer	5.7e-05	0.000258	CcSEcCtD
Levobupivacaine—Oedema—Prednisone—prostate cancer	5.7e-05	0.000258	CcSEcCtD
Levobupivacaine—Nausea—Mitoxantrone—prostate cancer	5.68e-05	0.000257	CcSEcCtD
Levobupivacaine—Infection—Prednisone—prostate cancer	5.66e-05	0.000257	CcSEcCtD
Levobupivacaine—Constipation—Docetaxel—prostate cancer	5.65e-05	0.000256	CcSEcCtD
Levobupivacaine—Pain—Docetaxel—prostate cancer	5.65e-05	0.000256	CcSEcCtD
Levobupivacaine—Dyspepsia—Capecitabine—prostate cancer	5.63e-05	0.000255	CcSEcCtD
Levobupivacaine—Chills—Epirubicin—prostate cancer	5.63e-05	0.000255	CcSEcCtD
Levobupivacaine—Pruritus—Etoposide—prostate cancer	5.63e-05	0.000255	CcSEcCtD
Levobupivacaine—Shock—Prednisone—prostate cancer	5.61e-05	0.000254	CcSEcCtD
Levobupivacaine—Arrhythmia—Epirubicin—prostate cancer	5.61e-05	0.000254	CcSEcCtD
Levobupivacaine—Nervous system disorder—Prednisone—prostate cancer	5.59e-05	0.000253	CcSEcCtD
Levobupivacaine—Tachycardia—Prednisone—prostate cancer	5.56e-05	0.000252	CcSEcCtD
Levobupivacaine—Decreased appetite—Capecitabine—prostate cancer	5.56e-05	0.000252	CcSEcCtD
Levobupivacaine—Skin disorder—Prednisone—prostate cancer	5.54e-05	0.000251	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Capecitabine—prostate cancer	5.52e-05	0.00025	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Prednisone—prostate cancer	5.51e-05	0.00025	CcSEcCtD
Levobupivacaine—Mental disorder—Epirubicin—prostate cancer	5.5e-05	0.000249	CcSEcCtD
Levobupivacaine—Constipation—Capecitabine—prostate cancer	5.47e-05	0.000248	CcSEcCtD
Levobupivacaine—Pain—Capecitabine—prostate cancer	5.47e-05	0.000248	CcSEcCtD
Levobupivacaine—Malnutrition—Epirubicin—prostate cancer	5.46e-05	0.000247	CcSEcCtD
Levobupivacaine—Erythema—Epirubicin—prostate cancer	5.46e-05	0.000247	CcSEcCtD
Levobupivacaine—Feeling abnormal—Docetaxel—prostate cancer	5.45e-05	0.000247	CcSEcCtD
Levobupivacaine—Diarrhoea—Etoposide—prostate cancer	5.44e-05	0.000247	CcSEcCtD
Levobupivacaine—Tinnitus—Doxorubicin—prostate cancer	5.41e-05	0.000245	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Docetaxel—prostate cancer	5.4e-05	0.000245	CcSEcCtD
Levobupivacaine—Cardiac disorder—Doxorubicin—prostate cancer	5.39e-05	0.000244	CcSEcCtD
Levobupivacaine—Flushing—Doxorubicin—prostate cancer	5.39e-05	0.000244	CcSEcCtD
Levobupivacaine—Flatulence—Epirubicin—prostate cancer	5.38e-05	0.000244	CcSEcCtD
Levobupivacaine—Tension—Epirubicin—prostate cancer	5.36e-05	0.000243	CcSEcCtD
Levobupivacaine—Nervousness—Epirubicin—prostate cancer	5.31e-05	0.00024	CcSEcCtD
Levobupivacaine—Back pain—Epirubicin—prostate cancer	5.28e-05	0.000239	CcSEcCtD
Levobupivacaine—Feeling abnormal—Capecitabine—prostate cancer	5.27e-05	0.000239	CcSEcCtD
Levobupivacaine—Dizziness—Etoposide—prostate cancer	5.26e-05	0.000238	CcSEcCtD
Levobupivacaine—Muscle spasms—Epirubicin—prostate cancer	5.25e-05	0.000238	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Capecitabine—prostate cancer	5.23e-05	0.000237	CcSEcCtD
Levobupivacaine—Abdominal pain—Docetaxel—prostate cancer	5.22e-05	0.000237	CcSEcCtD
Levobupivacaine—Body temperature increased—Docetaxel—prostate cancer	5.22e-05	0.000237	CcSEcCtD
Levobupivacaine—Chills—Doxorubicin—prostate cancer	5.21e-05	0.000236	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Prednisone—prostate cancer	5.19e-05	0.000235	CcSEcCtD
Levobupivacaine—Arrhythmia—Doxorubicin—prostate cancer	5.19e-05	0.000235	CcSEcCtD
Levobupivacaine—Insomnia—Prednisone—prostate cancer	5.16e-05	0.000234	CcSEcCtD
Levobupivacaine—Vision blurred—Epirubicin—prostate cancer	5.15e-05	0.000233	CcSEcCtD
Levobupivacaine—Paraesthesia—Prednisone—prostate cancer	5.12e-05	0.000232	CcSEcCtD
Levobupivacaine—Mental disorder—Doxorubicin—prostate cancer	5.09e-05	0.00023	CcSEcCtD
Levobupivacaine—Urticaria—Capecitabine—prostate cancer	5.08e-05	0.00023	CcSEcCtD
Levobupivacaine—Abdominal pain—Capecitabine—prostate cancer	5.06e-05	0.000229	CcSEcCtD
Levobupivacaine—Body temperature increased—Capecitabine—prostate cancer	5.06e-05	0.000229	CcSEcCtD
Levobupivacaine—Vomiting—Etoposide—prostate cancer	5.06e-05	0.000229	CcSEcCtD
Levobupivacaine—Erythema—Doxorubicin—prostate cancer	5.05e-05	0.000229	CcSEcCtD
Levobupivacaine—Malnutrition—Doxorubicin—prostate cancer	5.05e-05	0.000229	CcSEcCtD
Levobupivacaine—Anaemia—Epirubicin—prostate cancer	5.05e-05	0.000229	CcSEcCtD
Levobupivacaine—Agitation—Epirubicin—prostate cancer	5.02e-05	0.000227	CcSEcCtD
Levobupivacaine—Dyspepsia—Prednisone—prostate cancer	5.02e-05	0.000227	CcSEcCtD
Levobupivacaine—Headache—Etoposide—prostate cancer	4.98e-05	0.000226	CcSEcCtD
Levobupivacaine—Flatulence—Doxorubicin—prostate cancer	4.98e-05	0.000226	CcSEcCtD
Levobupivacaine—Tension—Doxorubicin—prostate cancer	4.96e-05	0.000225	CcSEcCtD
Levobupivacaine—Decreased appetite—Prednisone—prostate cancer	4.95e-05	0.000224	CcSEcCtD
Levobupivacaine—Nervousness—Doxorubicin—prostate cancer	4.91e-05	0.000222	CcSEcCtD
Levobupivacaine—Syncope—Epirubicin—prostate cancer	4.9e-05	0.000222	CcSEcCtD
Levobupivacaine—Back pain—Doxorubicin—prostate cancer	4.89e-05	0.000221	CcSEcCtD
Levobupivacaine—Constipation—Prednisone—prostate cancer	4.87e-05	0.000221	CcSEcCtD
Levobupivacaine—Hypersensitivity—Docetaxel—prostate cancer	4.87e-05	0.000221	CcSEcCtD
Levobupivacaine—Muscle spasms—Doxorubicin—prostate cancer	4.86e-05	0.00022	CcSEcCtD
Levobupivacaine—Palpitations—Epirubicin—prostate cancer	4.83e-05	0.000219	CcSEcCtD
Levobupivacaine—Loss of consciousness—Epirubicin—prostate cancer	4.8e-05	0.000217	CcSEcCtD
Levobupivacaine—Cough—Epirubicin—prostate cancer	4.77e-05	0.000216	CcSEcCtD
Levobupivacaine—Vision blurred—Doxorubicin—prostate cancer	4.76e-05	0.000216	CcSEcCtD
Levobupivacaine—Asthenia—Docetaxel—prostate cancer	4.74e-05	0.000215	CcSEcCtD
Levobupivacaine—Convulsion—Epirubicin—prostate cancer	4.73e-05	0.000214	CcSEcCtD
Levobupivacaine—Nausea—Etoposide—prostate cancer	4.72e-05	0.000214	CcSEcCtD
Levobupivacaine—Hypertension—Epirubicin—prostate cancer	4.72e-05	0.000214	CcSEcCtD
Levobupivacaine—Hypersensitivity—Capecitabine—prostate cancer	4.71e-05	0.000214	CcSEcCtD
Levobupivacaine—Feeling abnormal—Prednisone—prostate cancer	4.7e-05	0.000213	CcSEcCtD
Levobupivacaine—Pruritus—Docetaxel—prostate cancer	4.68e-05	0.000212	CcSEcCtD
Levobupivacaine—Anaemia—Doxorubicin—prostate cancer	4.67e-05	0.000212	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Prednisone—prostate cancer	4.66e-05	0.000211	CcSEcCtD
Levobupivacaine—Arthralgia—Epirubicin—prostate cancer	4.65e-05	0.000211	CcSEcCtD
Levobupivacaine—Agitation—Doxorubicin—prostate cancer	4.64e-05	0.00021	CcSEcCtD
Levobupivacaine—Anxiety—Epirubicin—prostate cancer	4.63e-05	0.00021	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.62e-05	0.000209	CcSEcCtD
Levobupivacaine—Asthenia—Capecitabine—prostate cancer	4.59e-05	0.000208	CcSEcCtD
Levobupivacaine—Syncope—Doxorubicin—prostate cancer	4.53e-05	0.000205	CcSEcCtD
Levobupivacaine—Urticaria—Prednisone—prostate cancer	4.53e-05	0.000205	CcSEcCtD
Levobupivacaine—Pruritus—Capecitabine—prostate cancer	4.53e-05	0.000205	CcSEcCtD
Levobupivacaine—Diarrhoea—Docetaxel—prostate cancer	4.52e-05	0.000205	CcSEcCtD
Levobupivacaine—Body temperature increased—Prednisone—prostate cancer	4.51e-05	0.000204	CcSEcCtD
Levobupivacaine—Abdominal pain—Prednisone—prostate cancer	4.51e-05	0.000204	CcSEcCtD
Levobupivacaine—Confusional state—Epirubicin—prostate cancer	4.49e-05	0.000204	CcSEcCtD
Levobupivacaine—Palpitations—Doxorubicin—prostate cancer	4.47e-05	0.000202	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Epirubicin—prostate cancer	4.46e-05	0.000202	CcSEcCtD
Levobupivacaine—Oedema—Epirubicin—prostate cancer	4.46e-05	0.000202	CcSEcCtD
Levobupivacaine—Loss of consciousness—Doxorubicin—prostate cancer	4.44e-05	0.000201	CcSEcCtD
Levobupivacaine—Infection—Epirubicin—prostate cancer	4.43e-05	0.000201	CcSEcCtD
Levobupivacaine—Cough—Doxorubicin—prostate cancer	4.41e-05	0.0002	CcSEcCtD
Levobupivacaine—Shock—Epirubicin—prostate cancer	4.39e-05	0.000199	CcSEcCtD
Levobupivacaine—Convulsion—Doxorubicin—prostate cancer	4.38e-05	0.000198	CcSEcCtD
Levobupivacaine—Diarrhoea—Capecitabine—prostate cancer	4.38e-05	0.000198	CcSEcCtD
Levobupivacaine—Nervous system disorder—Epirubicin—prostate cancer	4.37e-05	0.000198	CcSEcCtD
Levobupivacaine—Dizziness—Docetaxel—prostate cancer	4.37e-05	0.000198	CcSEcCtD
Levobupivacaine—Hypertension—Doxorubicin—prostate cancer	4.36e-05	0.000198	CcSEcCtD
Levobupivacaine—Tachycardia—Epirubicin—prostate cancer	4.35e-05	0.000197	CcSEcCtD
Levobupivacaine—Skin disorder—Epirubicin—prostate cancer	4.33e-05	0.000196	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Epirubicin—prostate cancer	4.31e-05	0.000195	CcSEcCtD
Levobupivacaine—Arthralgia—Doxorubicin—prostate cancer	4.3e-05	0.000195	CcSEcCtD
Levobupivacaine—Anxiety—Doxorubicin—prostate cancer	4.29e-05	0.000194	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	4.27e-05	0.000194	CcSEcCtD
Levobupivacaine—Dizziness—Capecitabine—prostate cancer	4.23e-05	0.000192	CcSEcCtD
Levobupivacaine—Vomiting—Docetaxel—prostate cancer	4.2e-05	0.00019	CcSEcCtD
Levobupivacaine—Hypersensitivity—Prednisone—prostate cancer	4.2e-05	0.00019	CcSEcCtD
Levobupivacaine—Hypotension—Epirubicin—prostate cancer	4.17e-05	0.000189	CcSEcCtD
Levobupivacaine—Confusional state—Doxorubicin—prostate cancer	4.16e-05	0.000188	CcSEcCtD
Levobupivacaine—Headache—Docetaxel—prostate cancer	4.14e-05	0.000188	CcSEcCtD
Levobupivacaine—Oedema—Doxorubicin—prostate cancer	4.12e-05	0.000187	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Doxorubicin—prostate cancer	4.12e-05	0.000187	CcSEcCtD
Levobupivacaine—Infection—Doxorubicin—prostate cancer	4.1e-05	0.000186	CcSEcCtD
Levobupivacaine—Asthenia—Prednisone—prostate cancer	4.09e-05	0.000185	CcSEcCtD
Levobupivacaine—Vomiting—Capecitabine—prostate cancer	4.07e-05	0.000184	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Epirubicin—prostate cancer	4.06e-05	0.000184	CcSEcCtD
Levobupivacaine—Shock—Doxorubicin—prostate cancer	4.06e-05	0.000184	CcSEcCtD
Levobupivacaine—Nervous system disorder—Doxorubicin—prostate cancer	4.05e-05	0.000183	CcSEcCtD
Levobupivacaine—Pruritus—Prednisone—prostate cancer	4.03e-05	0.000183	CcSEcCtD
Levobupivacaine—Insomnia—Epirubicin—prostate cancer	4.03e-05	0.000183	CcSEcCtD
Levobupivacaine—Tachycardia—Doxorubicin—prostate cancer	4.03e-05	0.000182	CcSEcCtD
Levobupivacaine—Headache—Capecitabine—prostate cancer	4.01e-05	0.000182	CcSEcCtD
Levobupivacaine—Skin disorder—Doxorubicin—prostate cancer	4.01e-05	0.000182	CcSEcCtD
Levobupivacaine—Paraesthesia—Epirubicin—prostate cancer	4e-05	0.000181	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Doxorubicin—prostate cancer	3.99e-05	0.000181	CcSEcCtD
Levobupivacaine—Dyspnoea—Epirubicin—prostate cancer	3.97e-05	0.00018	CcSEcCtD
Levobupivacaine—Somnolence—Epirubicin—prostate cancer	3.96e-05	0.00018	CcSEcCtD
Levobupivacaine—Nausea—Docetaxel—prostate cancer	3.93e-05	0.000178	CcSEcCtD
Levobupivacaine—Dyspepsia—Epirubicin—prostate cancer	3.92e-05	0.000178	CcSEcCtD
Levobupivacaine—Diarrhoea—Prednisone—prostate cancer	3.9e-05	0.000177	CcSEcCtD
Levobupivacaine—Decreased appetite—Epirubicin—prostate cancer	3.88e-05	0.000176	CcSEcCtD
Levobupivacaine—Hypotension—Doxorubicin—prostate cancer	3.85e-05	0.000175	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Epirubicin—prostate cancer	3.85e-05	0.000174	CcSEcCtD
Levobupivacaine—Constipation—Epirubicin—prostate cancer	3.81e-05	0.000173	CcSEcCtD
Levobupivacaine—Pain—Epirubicin—prostate cancer	3.81e-05	0.000173	CcSEcCtD
Levobupivacaine—Nausea—Capecitabine—prostate cancer	3.8e-05	0.000172	CcSEcCtD
Levobupivacaine—Dizziness—Prednisone—prostate cancer	3.77e-05	0.000171	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.76e-05	0.00017	CcSEcCtD
Levobupivacaine—Insomnia—Doxorubicin—prostate cancer	3.73e-05	0.000169	CcSEcCtD
Levobupivacaine—Paraesthesia—Doxorubicin—prostate cancer	3.7e-05	0.000168	CcSEcCtD
Levobupivacaine—Dyspnoea—Doxorubicin—prostate cancer	3.68e-05	0.000167	CcSEcCtD
Levobupivacaine—Feeling abnormal—Epirubicin—prostate cancer	3.67e-05	0.000166	CcSEcCtD
Levobupivacaine—Somnolence—Doxorubicin—prostate cancer	3.67e-05	0.000166	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Epirubicin—prostate cancer	3.65e-05	0.000165	CcSEcCtD
Levobupivacaine—Dyspepsia—Doxorubicin—prostate cancer	3.63e-05	0.000164	CcSEcCtD
Levobupivacaine—Vomiting—Prednisone—prostate cancer	3.62e-05	0.000164	CcSEcCtD
Levobupivacaine—Decreased appetite—Doxorubicin—prostate cancer	3.59e-05	0.000162	CcSEcCtD
Levobupivacaine—Headache—Prednisone—prostate cancer	3.57e-05	0.000162	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.56e-05	0.000161	CcSEcCtD
Levobupivacaine—Urticaria—Epirubicin—prostate cancer	3.54e-05	0.00016	CcSEcCtD
Levobupivacaine—Constipation—Doxorubicin—prostate cancer	3.53e-05	0.00016	CcSEcCtD
Levobupivacaine—Pain—Doxorubicin—prostate cancer	3.53e-05	0.00016	CcSEcCtD
Levobupivacaine—Abdominal pain—Epirubicin—prostate cancer	3.52e-05	0.00016	CcSEcCtD
Levobupivacaine—Body temperature increased—Epirubicin—prostate cancer	3.52e-05	0.00016	CcSEcCtD
Levobupivacaine—Feeling abnormal—Doxorubicin—prostate cancer	3.4e-05	0.000154	CcSEcCtD
Levobupivacaine—Nausea—Prednisone—prostate cancer	3.39e-05	0.000153	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Doxorubicin—prostate cancer	3.37e-05	0.000153	CcSEcCtD
Levobupivacaine—Hypersensitivity—Epirubicin—prostate cancer	3.28e-05	0.000149	CcSEcCtD
Levobupivacaine—Urticaria—Doxorubicin—prostate cancer	3.28e-05	0.000148	CcSEcCtD
Levobupivacaine—Body temperature increased—Doxorubicin—prostate cancer	3.26e-05	0.000148	CcSEcCtD
Levobupivacaine—Abdominal pain—Doxorubicin—prostate cancer	3.26e-05	0.000148	CcSEcCtD
Levobupivacaine—Asthenia—Epirubicin—prostate cancer	3.2e-05	0.000145	CcSEcCtD
Levobupivacaine—Pruritus—Epirubicin—prostate cancer	3.15e-05	0.000143	CcSEcCtD
Levobupivacaine—Diarrhoea—Epirubicin—prostate cancer	3.05e-05	0.000138	CcSEcCtD
Levobupivacaine—Hypersensitivity—Doxorubicin—prostate cancer	3.04e-05	0.000138	CcSEcCtD
Levobupivacaine—Asthenia—Doxorubicin—prostate cancer	2.96e-05	0.000134	CcSEcCtD
Levobupivacaine—Dizziness—Epirubicin—prostate cancer	2.95e-05	0.000134	CcSEcCtD
Levobupivacaine—Pruritus—Doxorubicin—prostate cancer	2.92e-05	0.000132	CcSEcCtD
Levobupivacaine—Vomiting—Epirubicin—prostate cancer	2.83e-05	0.000128	CcSEcCtD
Levobupivacaine—Diarrhoea—Doxorubicin—prostate cancer	2.82e-05	0.000128	CcSEcCtD
Levobupivacaine—Headache—Epirubicin—prostate cancer	2.79e-05	0.000127	CcSEcCtD
Levobupivacaine—Dizziness—Doxorubicin—prostate cancer	2.73e-05	0.000124	CcSEcCtD
Levobupivacaine—Nausea—Epirubicin—prostate cancer	2.65e-05	0.00012	CcSEcCtD
Levobupivacaine—Vomiting—Doxorubicin—prostate cancer	2.62e-05	0.000119	CcSEcCtD
Levobupivacaine—Headache—Doxorubicin—prostate cancer	2.58e-05	0.000117	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—KRAS—prostate cancer	2.54e-05	0.000295	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	2.53e-05	0.000294	CbGpPWpGaD
Levobupivacaine—Nausea—Doxorubicin—prostate cancer	2.45e-05	0.000111	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—COMT—prostate cancer	2.44e-05	0.000285	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.43e-05	0.000283	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	2.42e-05	0.000282	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.41e-05	0.000281	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.4e-05	0.000279	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	2.33e-05	0.000272	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	2.25e-05	0.000262	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.24e-05	0.00026	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADI1—prostate cancer	2.21e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PSAT1—prostate cancer	2.21e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CSAD—prostate cancer	2.21e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CBR1—prostate cancer	2.21e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GRHL1—prostate cancer	2.21e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TST—prostate cancer	2.21e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.2e-05	0.000257	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	2.16e-05	0.000251	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6—prostate cancer	2.14e-05	0.000249	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.12e-05	0.000247	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	2.12e-05	0.000247	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HAO1—prostate cancer	2.09e-05	0.000244	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	2.09e-05	0.000243	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6—prostate cancer	2.06e-05	0.00024	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UGT2B17—prostate cancer	2.05e-05	0.000239	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UGT2B15—prostate cancer	2.05e-05	0.000239	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GRHPR—prostate cancer	2.05e-05	0.000239	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CKMT2—prostate cancer	2.05e-05	0.000239	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	2.01e-05	0.000234	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—prostate cancer	1.97e-05	0.00023	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—prostate cancer	1.97e-05	0.00023	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM3—prostate cancer	1.93e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AOX1—prostate cancer	1.93e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NAGLU—prostate cancer	1.93e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—RFK—prostate cancer	1.93e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MBTPS1—prostate cancer	1.93e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PGAM2—prostate cancer	1.93e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SULT2B1—prostate cancer	1.93e-05	0.000225	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—prostate cancer	1.9e-05	0.000222	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	1.89e-05	0.00022	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AMACR—prostate cancer	1.83e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP3A43—prostate cancer	1.83e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—DEGS1—prostate cancer	1.83e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NAT1—prostate cancer	1.83e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SRD5A2—prostate cancer	1.83e-05	0.000213	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	1.8e-05	0.00021	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	1.79e-05	0.000208	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD17B1—prostate cancer	1.75e-05	0.000203	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	1.75e-05	0.000203	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GRHL1—prostate cancer	1.71e-05	0.000199	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADI1—prostate cancer	1.71e-05	0.000199	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PSAT1—prostate cancer	1.71e-05	0.000199	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CBR1—prostate cancer	1.71e-05	0.000199	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TST—prostate cancer	1.71e-05	0.000199	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CSAD—prostate cancer	1.71e-05	0.000199	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.68e-05	0.000196	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.67e-05	0.000194	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.65e-05	0.000192	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CKMT2—prostate cancer	1.59e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GRHPR—prostate cancer	1.59e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.59e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.59e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.58e-05	0.000183	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—B4GALT4—prostate cancer	1.56e-05	0.000181	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HPGD—prostate cancer	1.56e-05	0.000181	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—RFK—prostate cancer	1.49e-05	0.000174	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PGAM2—prostate cancer	1.49e-05	0.000174	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM3—prostate cancer	1.49e-05	0.000174	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.49e-05	0.000174	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.49e-05	0.000174	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AOX1—prostate cancer	1.49e-05	0.000174	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NAGLU—prostate cancer	1.49e-05	0.000174	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TNFRSF21—prostate cancer	1.46e-05	0.00017	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTAP—prostate cancer	1.42e-05	0.000166	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP7B1—prostate cancer	1.42e-05	0.000166	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AMACR—prostate cancer	1.41e-05	0.000164	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.41e-05	0.000164	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NAT1—prostate cancer	1.41e-05	0.000164	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.41e-05	0.000164	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—DEGS1—prostate cancer	1.41e-05	0.000164	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.39e-05	0.000162	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SULT1E1—prostate cancer	1.39e-05	0.000162	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SRD5A1—prostate cancer	1.39e-05	0.000162	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.35e-05	0.000157	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.35e-05	0.000157	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.33e-05	0.000155	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ACSL4—prostate cancer	1.32e-05	0.000154	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD17B3—prostate cancer	1.32e-05	0.000154	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	1.31e-05	0.000152	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ARG2—prostate cancer	1.27e-05	0.000148	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UMPS—prostate cancer	1.27e-05	0.000148	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PHGDH—prostate cancer	1.27e-05	0.000148	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.26e-05	0.000147	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LDHB—prostate cancer	1.24e-05	0.000145	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP3A5—prostate cancer	1.22e-05	0.000142	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HPGD—prostate cancer	1.2e-05	0.00014	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.2e-05	0.00014	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PDHA1—prostate cancer	1.18e-05	0.000137	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA3—prostate cancer	1.18e-05	0.000137	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UCP3—prostate cancer	1.18e-05	0.000137	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TCN2—prostate cancer	1.18e-05	0.000137	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.13e-05	0.000132	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD3B1—prostate cancer	1.13e-05	0.000131	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC22A3—prostate cancer	1.13e-05	0.000131	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.1e-05	0.000128	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTAP—prostate cancer	1.1e-05	0.000128	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.09e-05	0.000127	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA4—prostate cancer	1.08e-05	0.000126	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TBXAS1—prostate cancer	1.08e-05	0.000126	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.07e-05	0.000125	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.07e-05	0.000125	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.05e-05	0.000123	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA2—prostate cancer	1.05e-05	0.000122	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SULT1A1—prostate cancer	1.04e-05	0.000121	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCG5—prostate cancer	1.04e-05	0.000121	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ACSL4—prostate cancer	1.02e-05	0.000119	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD17B3—prostate cancer	1.02e-05	0.000119	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA1—prostate cancer	1.01e-05	0.000118	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTO1—prostate cancer	1e-05	0.000117	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD3B2—prostate cancer	1e-05	0.000117	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NAT2—prostate cancer	1e-05	0.000117	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ARG2—prostate cancer	9.79e-06	0.000114	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PHGDH—prostate cancer	9.79e-06	0.000114	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UMPS—prostate cancer	9.79e-06	0.000114	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	9.64e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LRP2—prostate cancer	9.62e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2C18—prostate cancer	9.62e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLCB2—prostate cancer	9.62e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LDHB—prostate cancer	9.6e-06	0.000112	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—P4HB—prostate cancer	9.43e-06	0.00011	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP3A5—prostate cancer	9.43e-06	0.00011	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC22A1—prostate cancer	9.17e-06	0.000107	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA3—prostate cancer	9.1e-06	0.000106	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PDHA1—prostate cancer	9.1e-06	0.000106	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UCP3—prostate cancer	9.1e-06	0.000106	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TCN2—prostate cancer	9.1e-06	0.000106	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	9.07e-06	0.000106	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SULT2A1—prostate cancer	8.94e-06	0.000104	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MED12—prostate cancer	8.8e-06	0.000102	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GNG5—prostate cancer	8.73e-06	0.000102	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC22A3—prostate cancer	8.69e-06	0.000101	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD3B1—prostate cancer	8.69e-06	0.000101	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NCOA3—prostate cancer	8.41e-06	9.79e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA4—prostate cancer	8.33e-06	9.69e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TBXAS1—prostate cancer	8.33e-06	9.69e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	8.26e-06	9.62e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA2—prostate cancer	8.11e-06	9.45e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HPGDS—prostate cancer	8.02e-06	9.34e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SULT1A1—prostate cancer	8.02e-06	9.33e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCG5—prostate cancer	8.02e-06	9.33e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2C19—prostate cancer	7.97e-06	9.28e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA1—prostate cancer	7.83e-06	9.12e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTT1—prostate cancer	7.78e-06	9.06e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ACHE—prostate cancer	7.78e-06	9.06e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NAT2—prostate cancer	7.74e-06	9.01e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTO1—prostate cancer	7.74e-06	9.01e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD3B2—prostate cancer	7.74e-06	9.01e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2A6—prostate cancer	7.69e-06	8.95e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	7.66e-06	8.92e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKR1C3—prostate cancer	7.48e-06	8.71e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PRKACB—prostate cancer	7.44e-06	8.66e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLCB2—prostate cancer	7.42e-06	8.64e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LRP2—prostate cancer	7.42e-06	8.64e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.42e-06	8.64e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP17A1—prostate cancer	7.36e-06	8.57e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—P4HB—prostate cancer	7.28e-06	8.47e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	7.26e-06	8.45e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC22A1—prostate cancer	7.08e-06	8.24e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NCOA2—prostate cancer	7.02e-06	8.17e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SULT2A1—prostate cancer	6.9e-06	8.03e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MED12—prostate cancer	6.79e-06	7.9e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GNG5—prostate cancer	6.73e-06	7.84e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SLC5A5—prostate cancer	6.69e-06	7.79e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2E1—prostate cancer	6.54e-06	7.61e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NCOA3—prostate cancer	6.49e-06	7.55e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NQO1—prostate cancer	6.46e-06	7.53e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TH—prostate cancer	6.37e-06	7.42e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	6.33e-06	7.37e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP3A4—prostate cancer	6.3e-06	7.34e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	6.27e-06	7.3e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP1B1—prostate cancer	6.2e-06	7.21e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HPGDS—prostate cancer	6.19e-06	7.21e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2C19—prostate cancer	6.15e-06	7.16e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTT1—prostate cancer	6e-06	6.99e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ACHE—prostate cancer	6e-06	6.99e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GGT1—prostate cancer	6e-06	6.99e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.93e-06	6.91e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NCOA1—prostate cancer	5.91e-06	6.88e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP19A1—prostate cancer	5.83e-06	6.78e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKR1C3—prostate cancer	5.77e-06	6.72e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PRKACB—prostate cancer	5.74e-06	6.68e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP17A1—prostate cancer	5.68e-06	6.62e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—RXRA—prostate cancer	5.62e-06	6.55e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	5.47e-06	6.37e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—COMT—prostate cancer	5.42e-06	6.31e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NCOA2—prostate cancer	5.41e-06	6.3e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTP1—prostate cancer	5.39e-06	6.28e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ITPR1—prostate cancer	5.3e-06	6.18e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	5.22e-06	6.07e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SLC5A5—prostate cancer	5.16e-06	6.01e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2E1—prostate cancer	5.04e-06	5.87e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TYMS—prostate cancer	5.01e-06	5.84e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NQO1—prostate cancer	4.99e-06	5.81e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM1—prostate cancer	4.95e-06	5.77e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TH—prostate cancer	4.92e-06	5.72e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—LPL—prostate cancer	4.86e-06	5.66e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.78e-06	5.57e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP1A1—prostate cancer	4.7e-06	5.47e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ERCC2—prostate cancer	4.66e-06	5.42e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GGT1—prostate cancer	4.63e-06	5.39e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NCOA1—prostate cancer	4.56e-06	5.31e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.5e-06	5.24e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTHFR—prostate cancer	4.38e-06	5.1e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—RXRA—prostate cancer	4.34e-06	5.05e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPARA—prostate cancer	4.3e-06	5e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—COMT—prostate cancer	4.18e-06	4.87e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTP1—prostate cancer	4.16e-06	4.84e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ITPR1—prostate cancer	4.09e-06	4.77e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CAV1—prostate cancer	4.04e-06	4.7e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TYMS—prostate cancer	3.87e-06	4.5e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.86e-06	4.49e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM1—prostate cancer	3.82e-06	4.45e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—LPL—prostate cancer	3.75e-06	4.37e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CG—prostate cancer	3.68e-06	4.28e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.62e-06	4.22e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ERCC2—prostate cancer	3.59e-06	4.19e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—INS—prostate cancer	3.48e-06	4.05e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CREBBP—prostate cancer	3.41e-06	3.97e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTHFR—prostate cancer	3.38e-06	3.93e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPARA—prostate cancer	3.31e-06	3.86e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CD—prostate cancer	3.23e-06	3.77e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CAV1—prostate cancer	3.12e-06	3.63e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NOS3—prostate cancer	3.05e-06	3.56e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.84e-06	3.31e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.82e-06	3.28e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTGS2—prostate cancer	2.79e-06	3.25e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—INS—prostate cancer	2.69e-06	3.13e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CREBBP—prostate cancer	2.63e-06	3.06e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.5e-06	2.91e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTEN—prostate cancer	2.44e-06	2.84e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NOS3—prostate cancer	2.36e-06	2.74e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—EP300—prostate cancer	2.32e-06	2.7e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.18e-06	2.53e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGS2—prostate cancer	2.16e-06	2.51e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTEN—prostate cancer	1.88e-06	2.19e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—EP300—prostate cancer	1.79e-06	2.09e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.72e-06	2e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—prostate cancer	1.4e-06	1.63e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.33e-06	1.54e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—prostate cancer	1.08e-06	1.26e-05	CbGpPWpGaD
